Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04645004 · ClinicalTrials.gov registry record · Phase 1
Antenatal Platelet Response on Aspirin: a Pharmacokinetic Study Through Pregnancy
A Phase 1 study, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT04645004 is a Phase 1 study that has completed, run by Thomas Jefferson University. The registered enrollment target is 20 participants.
The verdict
NCT04645004, a Phase 1 study, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
Longitudinal pharmacokinetic and pharmacodynamic study in first and third trimester of pregnancy
Interventions
- DRUG Aspirin 81Mg Non-enteric coated Tab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-12-29 |
| Est. Completion | 2024-03-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04645004
The ClinicalTrials.gov registry entry for NCT04645004 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Aspirin 81Mg Non-enteric coated Tab is the first listed.
NCT04645004 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04645004 about?
NCT04645004 is a clinical study titled "Antenatal Platelet Response on Aspirin: a Pharmacokinetic Study Through Pregnancy". Longitudinal pharmacokinetic and pharmacodynamic study in first and third trimester of pregnancy
What is the current status of trial NCT04645004?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2020-12-29. Estimated completion is 2024-03-15.
What interventions are being tested in trial NCT04645004?
The interventions under investigation include: Aspirin 81Mg Non-enteric coated Tab (DRUG).
Who is sponsoring clinical trial NCT04645004?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.